Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small...

[PDF] frontiersin.org

Efficacy of immune checkpoint inhibitor therapy in EGFR mutation-positive patients with NSCLC and brain metastases who have failed EGFR-TKI therapy

S Zhou, F Ren, X Meng - Frontiers in Immunology, 2022 - frontiersin.org
Background Few treatment options are available for brain metastases (BMs) in EGFR-
mutant non-small cell lung cancer (NSCLC) that progress with prior EGFR tyrosine kinase …
被引用次数：7 相关文章 所有 4 个版本
[PDF] zlfzyj.com

非小细胞肺癌脑转移放疗联合免疫治疗的研究进展

孙逸初， 梁飞， 夏铀铀 - 肿瘤防治研究, 2023 - zlfzyj.com
肺癌是全球第二大常见癌症, 其中高达40% 的非小细胞肺癌患者会发生脑转移.
放疗是脑转移瘤的重要局部治疗手段, 而近年来免疫治疗也成为治疗晚期非小细胞肺癌的重要 …
相关文章 所有 3 个版本
[PDF] frontiersin.org

RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis

M Wu, J Jiang, X Zhang, J Chen, Q Chang… - Frontiers in …, 2022 - frontiersin.org
Introduction Radiotherapy (RT) is currently the main treatment for brain metastases (BMs)
from non-small cell lung cancer (NSCLC). Due to the short survival time and obvious …
相关文章 所有 5 个版本
[PDF] degruyter.com

Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis

C Zhang, W Zhou, D Zhang, S Ma, X Wang, W Jia… - Open …, 2023 - degruyter.com
More clinical evidence is needed regarding the relative priority of treatments for brain
metastases (BMs) from EGFR/ALK-negative/unselected non-small cell lung cancer …
相关文章 所有 8 个版本
[PDF] zlfzyj.com

Progress of Research on Radiotherapy Combined with Immunotherapy for Brain Metastases from Non-small Cell Lung Cancer

SUN Yichu, L Fei, XIA Youyou - Cancer Research on Prevention and …, 2023 - zlfzyj.com
Lung cancer is the second most common cancer worldwide, and 40% of patients with non-
small cell lung cancer may develop brain metastases. Radiotherapy is a classic treatment for …
相关文章 所有 3 个版本